Alkermes at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Alkermes brings 2 presentations to SfN 2026 in Washington. Its SfN 2026 presentations centre on how psychiatric and anti-epileptic drugs affect neural activity. One thread uses multi-electrode arrays to investigate how anti-epileptic drugs affect neuronal network activity.

OrganizationSfN 2026 Attendance
Alkermes
Waltham, MA
alkermes.com
Drug developers
Biopharmaceutical company developing medicines for neurologic and psychiatric disorders.
Poster
Sun Nov 15
8am–noon
Poster
Sun Nov 15
1–5pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Alkermes

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction